Biotech Values

[DewDiligence]

Further to the same story:

No doubt this is bad; however, I predict that a year from now biotech stocks will be higher and Marks won't be missed by biotech investors.

— Roy Friedman (@DewDiligence) March 29, 2025

The fallout may be painful, but I'm confident that it will be short-lived. In no way is the FDA "doomed." I think you'll come to regret having said that, Adam.

— Roy Friedman (@DewDiligence) March 29, 2025